Antidopaminergic Medications and Clinical Changes in Measures of Huntington's Disease: A Causal Analysis
ADM use was associated with more rapid change in clinical measures, particularly in cognitive and functional domains. However, assumptions required to establish causation between ADM use and disease progression may not have been fully met, and further research is warranted. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Authors
- Andrew M. Tan (ORCID: https://orcid.org/0000-0002-0099-8814)
- Jeffrey D. Long (ORCID: https://orcid.org/0000-0001-7181-9652)
- Michael R. Hayden (ORCID: https://orcid.org/0000-0001-5159-1419)
- Michal Geva (ORCID: https://orcid.org/0000-0002-6949-0963)
- Y. Paul Goldberg
- Henk Schuring
Institutions
- University of Iowa (US)
- University of British Columbia (CA)
- Yale University (US)
- Unilever (Netherlands) (NL)
Publication Details
- Journal
- Movement Disorders
- Published
- 2025-03-18
- DOI
- https://doi.org/10.1002/mds.30164
- Citations
- 4
- Primary Topic
- Genetic Neurodegenerative Diseases
- Type
- article
- Field-Weighted Citation Impact
- 3.64